semaglutide patent expiry 2031 No Generics Approved in China One Month After The semaglutide story: highlighting the

For semaglutide users, this translates to a practical benefit

Serious side effects can include: acute pancreatitis (sudden inflammation of the pancreas) acute gallbladder disease, such as gallstones low blood sugar severe digestive side effects, which may lead to dehydration or acute kidney injury diabetic retinopathy (diabetes-related eye damage) increases in heart rate suicidal thoughts or behaviors (when the drug is used for weight loss) risk of thyroid cancer* * Semaglutide has a boxed warning for this side effect

Direct effects come from GLP-1 receptor activity in the liver and gut, which reduces fat production and absorption independent of calorie intake

Once FDA-approved (expected 2027), the commercial price will likely be $1,0001,500/month before insurance, based on tirzepatide and semaglutide pricing

53.9%, RR = 0.33) and mortality (5.8% vs